INCY logo

INCY
Incyte Corp.

5,593
Mkt Cap
$19.25B
Volume
905,081.00
52W High
$112.29
52W Low
$57.77
PE Ratio
14.91
INCY Fundamentals
Price
$95.47
Prev Close
$96.74
Open
$96.37
50D MA
$96.27
Beta
0.59
Avg. Volume
1.68M
EPS (Annual)
$6.41
P/B
3.67
Rev/Employee
$1.81M
$16,297.46
Loading...
Loading...
News
all
press releases
Ruffer LLP Has $2.51 Million Holdings in Incyte Corporation $INCY
Ruffer LLP cut its holdings in Incyte Corporation (NASDAQ:INCY - Free Report) by 42.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
MINJUVI (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
MINJUVI (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia MINJUVI (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia PR Newswire...
PR Newswire·22h ago
News Placeholder
Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2d ago
News Placeholder
Incyte Corporation $INCY Stock Holdings Raised by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Incyte Corporation (NASDAQ:INCY - Free Report) by 67.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 208,927 shares of the biopharmaceutical company's stock after purchasing a...
MarketBeat·2d ago
News Placeholder
Incyte (NASDAQ:INCY) Insider Pablo Cagnoni Sells 18,667 Shares
Incyte Corporation (NASDAQ:INCY - Get Free Report) insider Pablo Cagnoni sold 18,667 shares of the company's stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $96.50, for a total transaction of $1,801,365.50. Following the sale, the insider directly owned...
MarketBeat·2d ago
News Placeholder
31,459 Shares in Incyte Corporation $INCY Bought by CPC Advisors LLC
CPC Advisors LLC bought a new position in shares of Incyte Corporation (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
Incyte (NASDAQ:INCY) Insider Sells $1,801,365.50 in Stock
Incyte Corporation (NASDAQ:INCY - Get Free Report) insider Pablo Cagnoni sold 18,667 shares of the business's stock in a transaction dated Friday, April 17th. The shares were sold at an average price...
MarketBeat·2d ago
News Placeholder
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Incyte (Nasdaq:INCY) today announced that full results from the Phase 3 pivotal study evaluating tafasitamab (Monjuvi/Minjuvi) in first-line diffuse large b-cell lymphoma (DLBCL) will be featured as...
Business Wire·3d ago
News Placeholder
Incyte (INCY) Projected to Post Earnings on Tuesday
Incyte (NASDAQ:INCY) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at...
MarketBeat·3d ago
<
1
2
...
>

Latest INCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.